Less Ads, More Data, More Tools Register for FREE

Pin to quick picksValiRx Share News (VAL)

Share Price Information for ValiRx (VAL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.95
Bid: 2.90
Ask: 3.00
Change: 0.00 (0.00%)
Spread: 0.10 (3.448%)
Open: 2.95
High: 2.95
Low: 2.95
Prev. Close: 2.95
VAL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: Stocks head higher as pound tops USD1.28 again

Fri, 16th Jun 2023 08:47

(Alliance News) - Stock prices in London opened higher on Friday, taking their cue from Asian and US equities, while investors weighed recent interest rate decisions.

The FTSE 100 index opened up 25.03 points, 0.3%, at 7,653.27. The FTSE 250 was up 47.47 points, 0.3%, at 19,086.88, and the AIM All-Share was up 2.50 points, 0.3%, at 794.06.

The Cboe UK 100 was up 0.3% at 763.65, the Cboe UK 250 was 0.2% at 16,654.07, and the Cboe Small Companies was up 0.2% at 13,923.00.

"The UK market is on its own streak this week, with yesterday marking the fourth consecutive session of gains as investors try and make heads or tails of mixed data from around the globe," said Hargreaves Lansdown's Matt Britzman.

In a week dominated by central bank decisions elsewhere, market attention is shifting to the BoE's own decision next Thursday. The pound continued its upward trajectory, as sticky inflation data, combined with strong employment and economic growth prints, set the stage for the BoE to continue its rate-hiking cycle.

Sterling was quoted at USD1.2788 early Friday, rising from USD1.2759 at the London equities close on Thursday. The pound had risen past the USD1.28 mark shortly after Friday's equity market open in London. Sterling traded at its best level since April 2022.

The latest central bank decision came from the Bank of Japan, which said it would maintain its long-standing, ultra-loose monetary policy as it looks to boost economic growth.

It left its negative interest rate in place and did not adjust the band in which rates for 10-year government bonds fluctuate, a scheme known as yield curve control

Against the yen, the dollar was quoted at JPY140.74, up versus JPY140.52.

Officials had been widely expected to keep policies unchanged after the second two-day meeting chaired by new Governor Kazuo Ueda.

The central bank has gone against the grain as its global peers hike interest rates to tackle inflation, pushing down the value of the yen against the dollar.

The Nikkei 225 index in Tokyo closed up 0.7%, consolidating recent highs on the back of the weak yen.

"The overbought market conditions, and the idea that Japan will, one day in our lifetime, normalize rates could lead to some profit taking, but it's also true that companies in geopolitically sensitive sectors like defence and semiconductors have been major drivers of the rally this year, and there is no reason for that appetite to change when the geopolitical landscape remains this tense," said Swissquote Bank's Ipek Ozkardeskaya.

In China, the Shanghai Composite was up 0.3%, while the Hang Seng index in Hong Kong was up 1.4%. The S&P/ASX 200 in Sydney closed up 1.1%.

Asian equities got a boost after China's central bank cut a key interest rate and injected USD33 billion into financial markets on Thursday. This comes after recent data suggested the country's economic recovery was flagging.

Gold was quoted at USD1,961.01 an ounce early Friday, up from USD1,955.88 on Thursday. Brent oil fetched USD75.75 a barrel, rising from USD74.81.

In European equities on Friday, the CAC 40 in Paris was up 0.1%, while the DAX 40 in Frankfurt was flat.

The euro traded at USD1.0952 early Friday, higher than USD1.0930 late Thursday.

The ECB lifted interest rates in the eurozone by 25 basis points, as expected, on Thursday. The Frankfurt-based central bank acknowledged in its statement on Thursday that inflation has been coming down, but is nonetheless projected to remain "too high for too long".

ECB President Christine Lagarde said a pause was not even an option for the ECB. Her words suggest a hike in July is all but assured, and that the September meeting is also a live one.

Stocks on Wall Street rallied on Thursday, despite hawkish rhetoric from the US Federal Reserve, with the Dow Jones Industrial Average up 1.3%, while the S&P 500 and the Nasdaq Composite both rose 1.2%.

The Federal Reserve left interest rates unchanged on Wednesday but signalled further increases were on the way before the end of the year. But with US two-year Treasury yields narrowing to around 4.65% late Thursday, from 4.69% ahead of the Fed decision on Wednesday, there is a sign some investors are not buying the central bank's hawkish narrative.

In London's FTSE 100 index, Tesco fell 1.1%

The company said it was seeing signs that inflation is easing in the grocery market, and the supermarket chain backed annual guidance as it kicked off its financial year with a sales hike.

Tesco said revenue in the 13 weeks to May 27, its first quarter, rose 9.4% to GBP15.17 billion. The measure excludes both VAT and fuel, but includes Tesco Bank.

Looking ahead, Tesco said it still expects retail free cash flow within its GBP1.4 billion to GBP1.8 billion target range. At best, this would be a 16% fall from GBP2.13 billion in financial 2023.

It still expects a "broadly flat level" of retail adjusted operating profit. Retail adjusted operating profit fell 6.1% to GBP2.49 billion from GBP2.65 billion in financial 2023.

"Tesco is managing the weakening consumer landscape about as well as possible. That's being helped by the group's enormous scale... The mature, deeply rooted, nature of its relationships has been a key tool in helping to keep prices down," said HL's Aarin Chiekrie.

Meanwhile, among mid-caps, Travis Perkins slumped 7.6%.

The builders' merchant said it had delivered a "resilient" performance in the first quarter of 2023, but it has not seen the anticipated easing of market conditions in the second quarter to date.

"Volumes in both the new build housing and private domestic RMI markets continue to be impacted by higher interest rates and weaker consumer confidence driven by persistent, higher than anticipated consumer price inflation," Travis Perkins said.

ITV fell 0.6%. The media company and broadcaster confirmed a Reuters report from Thursday that it is considering an acquisition of production group All3Media. All3Media is jointly owned by Warner Bros Discovery and Liberty Global. According to Reuters sources, ITV is considering combining the business with its Studios unit, and Liberty Global could possibly retain a stake. As well as jointly-owning All3Media, Liberty Global has a roughly 9.9% stake in ITV.

Reuters had previously reported All3Media, which produces Fleabag and Midsomer Murders, could fetch a price tag over GBP1 billion.

On AIM, ValiRx fell 15%

The life sciences company, which focuses on early-stage cancer therapeutics and women's health, said it has concluded its evaluation agreement with Hokkaido University.

"Under this agreement, ValiRx committed to conducting a range of experiments following initial confirmation of the synthetic route and analysis. After overcoming initial challenges in synthesis and purification of the peptide, testing has been conducted on the product," it explained.

The product was subsequently found to be "unsuitable" for further development, and the evaluation will now end.

Still to come on Friday's economic calendar, there's a eurozone inflation reading at 1000 BST.

By Elizabeth Winter, Alliance News senior markets reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
14 Jul 2016 08:50

ValiRx Receives Approval To Submit Application For Cancer Drug Trial

Read more
7 Jul 2016 07:50

ValiRx Sells TRAC Technology To Germany's Sovicell For EUR800,000

Read more
13 Jun 2016 15:02

UK Shareholder Meetings Calendar - Next 7 Days

Read more
7 Jun 2016 09:19

ValiRx Highlights Progress With VAL201 Lead Compound, VAL401 Venture

Read more
19 May 2016 15:44

ValiRx updates market on 'significant' 2015

(ShareCast News) - Lifesciences company ValiRx reported on a "significant year" on Thursday, talking up its capital restructure and technical advancements in the 2015 calendar year. The AIM-traded firm, which focuses on cancer therapeutics and diagnostics for personalised medicine, said its Phase I/

Read more
19 May 2016 10:29

ValiRx Loss Narrows As Progress Is Made On Cancer Compounds

Read more
19 May 2016 09:23

ValiRx Says ValiSeek Begins Manufacturing VAL401 For Clinical Trial

Read more
29 Apr 2016 07:50

ValiRx Says ValiSeek Gets US Patent For VAL401 In Adenocarcinoma

Read more
19 Apr 2016 14:45

ValiRx Shares Fall After Bracknor Converts GBP200,000 Of Loan Notes (ALLISS)

Read more
1 Apr 2016 14:28

ValiRx Receives Conversion Notice For GBP90,000 From Bracknor (ALLISS)

Read more
21 Mar 2016 08:29

ValiRx Strikes GBP4 Million Convertible Funding Deal With Bracknor (ALLISS)

Read more
17 Mar 2016 09:07

ValiRx Hires Consultancy Firm Burns McClellan To Boost US Profile

Read more
17 Feb 2016 13:04

ValiRx Raises Funds To Back Ongoing Drug Trials (ALLISS)

Read more
16 Feb 2016 13:17

ValiRx achieves success in latest VAL201 trial

(ShareCast News) - ValiRx was pressing ahead with the trial process for its VAL201 trial treatment on Tuesday, following positive results from the most recent tranche of test patients. The AIM-traded life science company, with a focus on cancer diagnostics and therapeutics for personalised medicine,

Read more
16 Feb 2016 09:16

ValiRx Says Final Dose Escalation For VAL201 Trials Approved

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.